This information is for educational purposes only. It is not intended as medical advice. Always consult a qualified healthcare professional.
HealthdirectFree Australian health advice you can count on. — Description, Dosage, Side Effects | PillsCard
OTC
HealthdirectFree Australian health advice you can count on.
45 mg/.5mL, Injection, solution
INN: USTEKINUMAB
Available in:
🇬🇧
Form
INJECTION, SOLUTION
Dosage
45 mg/.5mL
Route
SUBCUTANEOUS
Storage
—
About This Product
Manufacturer
Nuvaila Limited
ATC Code
User Reviews
Reviews reflect personal experiences and are not medical advice. Always consult your doctor.
L04AC05
Source
OPENFDA_NDC
(
ARTG
)
--Crohns Disease-- WEZLANA is indicated for the treatment of adult patients with moderately to severely active Crohns disease who have had an inadequate response, lost response, or were intolerant to either conventional therapy or a TNF alpha antagonist or have medical contraindications to such therapies.,--Ulcerative Colitis-- WEZLANA is indicated for the treatment of adult patients with moderately to severely active ulcerative colitis.
⚠️ Warnings
• Caution should be exercised in patients with history of infection, tuberculosis (TB), cancer, nerve disorder called reversible posterior leukoencephalopathy syndrome (RPLS), poor immunity, flu-like symptoms, received a vaccine, any allergy, who are taking other medications, during pregnancy and breastfeeding.
• TB skin test should be performed before using this medication.
• Avoid contact with people who infections that can be spread to others.
• Avoid live vaccination during the treatment period.
♦
Patient may develop increased risk of infections. If it is so consult with your healthcare provider.
♦
It may increase the risk of malignancy.
PillsCard reference image